An unusual case report illuminates the therapeutic potential of psilocybin and neuroplasticity.
Read morePharmacists and Safe Consumption of Psychedelic Medicines Upon Their FDA Approval
Upon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreEcstasy and Psilocybin Are Shaking Up Psychiatry
Researchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read moreTest Psilocybin Potency at Home
Want to measure the magic in your mushrooms? The miraculix test kit shows the percentage of psilocybin in your mushrooms.
Read moreMDMA Risks
Gabriel Kearns, M.D. shares important and life-saving harm reduction information in this interview on MDMA.
Read moreIbogaine and 5-MeO-DMT for Traumatic Brain Injuries
Check out this interview with Amber Capone of VETS, on studying ibogaine and 5-MeO-DMT for traumatic brain injuries.
How Mushrooms Started Going Mainstream
In the 1950s, Gordon and Valentina Wasson encountered magic mushrooms. Then they wouldn’t stop talking about them.
Read moreLooking at Psychedelics and Legalization
Michael Pollan looks at the legalization of some psychedelics and asks how should we do drugs now?
Read moreCan a Bad Trip Be a Good Thing?
Psychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read morePsychedelics As Medicine
Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read more